SELARSDI
Live / Registered — Registered (as of 10 Feb 2026)
What this means for you
Registered since 10 Feb 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Feb 2032: the §8 declaration of use).
Record
- Serial number
- 97477128
- Registration number
- 8137673
- Mark type
- Word mark
- Filed
- 27 Jun 2022
- Published for opposition
- 16 May 2023
- Registered
- 10 Feb 2026
- Next maintenance filing
- §8 declaration of use, due by 10 Feb 2032 (grace period to 10 Aug 2032)
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of auto-immune disease
Owner
- Teva Pharmaceuticals USA, Parsippany, NJ
- Teva Pharmaceuticals USA, Parsippany, NJ
- Teva Pharmaceuticals USA, Parsippany, NJ
Prosecution history
- 10 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Jun 2025 — USE AMENDMENT FILED
- 03 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Dec 2024 — SOU EXTENSION 3 GRANTED
- 18 Dec 2024 — SOU EXTENSION 3 FILED
- 18 Dec 2024 — SOU TEAS EXTENSION RECEIVED